Canopy Growth Corp vs Global X Defense Tech ETF — how do they compare? Canopy Growth Corp trades at $1.03 (market cap $421.10M), while Global X Defense Tech ETF trades at $70.13. The key difference: Global X Defense Tech ETF is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | SHLD | |
|---|---|---|
Market Cap | $421.10M | — |
Sector | Health | Sector/Thematic |
52-Week High | $1.92 | $78.02 |
52-Week Low | $0.86 | $58.20 |
Enterprise Value | $378.55M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
SHLD, the Global X Defense Tech ETF, trades at $70.08, up 0.33% with a bullish technical signal from moving averages but overbought RSI readings. Recent news highlights institutional accumulation, including Focus Financial Network increasing its stake by 55.4% in Q2 2026 (Defense World, 2026-08-11). The ETF provides diversified exposure to global defense stocks amid rising military spending trends.
Outlook is supported by geopolitical tensions and defense budget growth, but risks include policy shifts and valuation concerns. Analysts note SHLD's lower fees and tech focus versus peers, with a dividend of $0.19 scheduled for July 2026. Key resistance is at $70, with support at $69.
Trailing returns across standard periods
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →